Department of Orthopaedic Surgery, Research School Caphri, Maastricht University Medical Centre, Maastricht, The Netherlands.
Injury. 2011 Sep;42 Suppl 2:S82-6. doi: 10.1016/j.injury.2011.06.189. Epub 2011 Jul 16.
Treatment of infection in clinical orthopaedic and trauma care is a time consuming and costly endeavour. More than once, it will lead to extraction of implant material and additional surgical interventions. Currently, debridement, implantation of PMMA beads impregnated with antibiotics most often with implant exchange are the gold standard for deep infection treatment. Recently bone graft substitute materials such as calcium phosphate, collagen fleeces and bioglasses have appeared for specific use in infection treatment. Although these materials show great potential, their supporting level of evidence is still limited. This review paper provides an overview of current understanding and therapies for infection treatment and provides concepts for the use of new developed biomaterials in infection treatment. Furthermore, the benefits and risks of using biomaterials in infection treatment are discussed and the level of evidence of a number of new materials is presented.
在临床骨科和创伤护理中,感染的治疗是一项耗时且昂贵的工作。这种情况不止一次地导致植入物材料的取出和额外的手术干预。目前,清创术、植入抗生素浸渍 PMMA 珠粒(通常需要进行植入物更换)是深部感染治疗的金标准。最近,磷酸钙、胶原绒毛和生物玻璃等骨移植替代材料已专门用于感染治疗。尽管这些材料显示出巨大的潜力,但它们的证据支持水平仍然有限。本文综述了感染治疗的现有认识和治疗方法,并为新型生物材料在感染治疗中的应用提供了概念。此外,还讨论了在感染治疗中使用生物材料的益处和风险,并介绍了一些新材料的证据水平。